APTOSE BIOSCIENCES INC. (APTOF) Free cash flow 2017–2025
APTOSE BIOSCIENCES INC. (APTOF) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$22.0MFY2025 · since FY2017: -$10.2M → -$22.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$22.0M | +38.9% |
| FY2024 | -$36.0M | +19.4% |
| FY2023 | -$44.6M | -37.9% |
| FY2022 | -$32.3M | +25.7% |
| FY2021 | -$43.5M | -28.1% |
| FY2020 | -$34.0M | -56.8% |
| FY2019 | -$21.7M | +8.0% |
| FY2018 | -$23.5M | -129.9% |
| FY2017 | -$10.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice